September 29, 2016 8:48 AM ET


Company Overview of Fovea Pharmaceuticals SA

Company Overview

Fovea Pharmaceuticals SA discovers and develops of drugs for the treatment of ocular diseases. It provides FOV1101/Prednisporin for the treatment of allergic conjunctivitis; FOV2302, a proprietary plasma kallikrein-kinin inhibitor for systemic treatment of hereditary angioedema; FOV2304 for the treatment of diabetic macular edema; and FOV2501, an intravitreal formulation of RdCVF designed to treat retinitis pigmentosa with extension to dry age related macular degeneration. The company was founded in 2005 and is based in Paris, France. As of October 30, 2009, Fovea Pharmaceuticals SA operates as a subsidiary of Sanofi.

12 rue Jean-Antoine de Baif

Paris,  75013


Founded in 2005


33 1 44 16 42 42


33 1 44 16 42 40

Key Executives for Fovea Pharmaceuticals SA

Chief Financial Officer and Strategic Controller
Administration and Finance Director
Head of Division Office
Senior Director of Strategy and Operations
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
A.T.O. ZIZINE S.A.S Europe
Advicenne Pharma SA Europe
Aerocid Europe
AG Pharma Europe
Aguettant Santé S.A. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fovea Pharmaceuticals SA, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at